ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Neurogene closes $115m series B financing pharmaceutical-business-review
December 21, 2020Neurogene, a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the completion of a $115m Series B financing. -
Neurogene announces EMA grants orphan drug designation for aspartylglucosaminuria gene therapy pharmaceutical-business-review
December 09, 2020Neurogene announces that the European Medicines Agency (EMA) has granted orphan drug designation (ODD) to its adeno-associated virus vector (AAV) with engineered transgene encoding the human AGA gene for patients diagnosed with aspartylglucosaminuria. -
Neurogene raises funds to support gene therapy development pharmaceutical-technology
February 15, 2019Neurogene has secured funding during a Series A financing round to advance the development of its gene therapy candidates intended for the treatment of various neurological diseases....
Pharma Sources Insight January 2025
